does tirzepatide cause cancer GLP-1s appear to cut risk. Researchers are asking why and how : NPR GLP-1RA and thyroid cancer: New

Because BPC 157 is not FDA-approved for medical use, there is no standardized approved dose, schedule, or route of administration

At minimum, this decision needs before-and-after numbers on IGF-1, fasting glucose, HbA1c, fasting insulin, plus lipids, blood pressure and fluid symptoms

The key parameter used is an 8% gross profit margin figure disclosed by the Big 3 PBMs themselves

Ying Che, Xiaolong Lu, Xueting Wang, Zhien Liu, Liyang Guan, Xin Li, Zaixing Du, Hang Ren, Jihong Wang, Zunchun Zhou, Li Lv Cancer Cell International .2024;[Epub] CrossRef Similar recurrence after curative treatment of HBV-related HCC, regardless of HBV replication activity Mi Na Kim, Beom Kyung Kim, Heejin Cho, Myung Ji Goh, Yun Ho Roh, Su Jong Yu, Dong Hyun Sinn, Soo Young Park, Seung Up Kim, Tyng-Yuan Jang PLOS ONE .2024

Gavrovic-Jankulovic M, Prodanovic R